Decode, Pfizer Collaborate on Sequence Variants for Lupus | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Decode Genetics today announced a research collaboration with Pfizer targeting sequence variants associated with specific clinical phenotypes related to systemic lupus erythematosis.

During the next 18 months, the firms will analyze the genomes of patients to discover sequence variants that could shed light on drug targets and lead to new drug targets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.